281 related articles for article (PubMed ID: 34019961)
1. E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis.
Shen D; Gao Y; Huang Q; Xuan Y; Yao Y; Gu L; Huang Y; Zhang Y; Li P; Fan Y; Tang L; Du S; Wu S; Wang H; Wang C; Gong H; Pang Y; Ma X; Wang B; Zhang X
Cancer Lett; 2021 Aug; 514():48-62. PubMed ID: 34019961
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the AMPK-GATA3-ECHS1 Pathway Induces Fatty Acid Synthesis That Promotes Clear Cell Renal Cell Carcinoma Growth.
Qu YY; Zhao R; Zhang HL; Zhou Q; Xu FJ; Zhang X; Xu WH; Shao N; Zhou SX; Dai B; Zhu Y; Shi GH; Shen YJ; Zhu YP; Han CT; Chang K; Lin Y; Zang WD; Xu W; Ye DW; Zhao SM; Zhao JY
Cancer Res; 2020 Jan; 80(2):319-333. PubMed ID: 31690668
[TBL] [Abstract][Full Text] [Related]
3. PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability.
Chen S; He Z; Peng T; Zhou F; Wang G; Qian K; Ju L; Xiao Y; Wang X
JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34499617
[TBL] [Abstract][Full Text] [Related]
4. SREBP1-driven lipid desaturation supports clear cell renal cell carcinoma growth through regulation of NF-κB signaling.
Yang H; Zhang X; Liu F; Fan J; Wang B; Dong C
Biochem Biophys Res Commun; 2018 Jan; 495(1):1383-1388. PubMed ID: 29183723
[TBL] [Abstract][Full Text] [Related]
5. NEIL3 promotes cell proliferation of ccRCC via the cyclin D1-Rb-E2F1 feedback loop regulation.
Zhang M; Jiang Y; Wang J; Yue Y; Liu W; Wang L; Li Y; Wang W; Cai H; Yang Z; Ma M; Lu S; Fan J
DNA Repair (Amst); 2024 Jan; 133():103604. PubMed ID: 37992567
[TBL] [Abstract][Full Text] [Related]
6. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of E2F1 promotes tumor malignancy and correlates with TNM stages in clear cell renal cell carcinoma.
Ma X; Gao Y; Fan Y; Ni D; Zhang Y; Chen W; Zhang P; Song E; Huang Q; Ai Q; Li H; Wang B; Zheng T; Shi T; Zhang X
PLoS One; 2013; 8(9):e73436. PubMed ID: 24023875
[TBL] [Abstract][Full Text] [Related]
8. SETD8 stabilized by USP17 epigenetically activates SREBP1 pathway to drive lipogenesis and oncogenesis of ccRCC.
Li X; Liu Z; Xia C; Yan K; Fang Z; Fan Y
Cancer Lett; 2022 Feb; 527():150-163. PubMed ID: 34942305
[TBL] [Abstract][Full Text] [Related]
9. SREBP-1c as a molecular bridge between lipogenesis and cell cycle progression of clear cell renal carcinoma.
Sethi G; Shanmugam MK; Kumar AP
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29138263
[TBL] [Abstract][Full Text] [Related]
10. The LINC01138 interacts with PRMT5 to promote SREBP1-mediated lipid desaturation and cell growth in clear cell renal cell carcinoma.
Zhang X; Wu J; Wu C; Chen W; Lin R; Zhou Y; Huang X
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):337-342. PubMed ID: 30446222
[TBL] [Abstract][Full Text] [Related]
11. A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma.
Syafruddin SE; Rodrigues P; Vojtasova E; Patel SA; Zaini MN; Burge J; Warren AY; Stewart GD; Eisen T; Bihary D; Samarajiwa SA; Vanharanta S
Nat Commun; 2019 Mar; 10(1):1152. PubMed ID: 30858363
[TBL] [Abstract][Full Text] [Related]
12. KLF6 Suppresses Metastasis of Clear Cell Renal Cell Carcinoma via Transcriptional Repression of E2F1.
Gao Y; Li H; Ma X; Fan Y; Ni D; Zhang Y; Huang Q; Liu K; Li X; Wang L; Gu L; Yao Y; Ai Q; Du Q; Song E; Zhang X
Cancer Res; 2017 Jan; 77(2):330-342. PubMed ID: 27780824
[TBL] [Abstract][Full Text] [Related]
13. SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism.
Sun Y; He W; Luo M; Zhou Y; Chang G; Ren W; Wu K; Li X; Shen J; Zhao X; Hu Y
Tumour Biol; 2015 Jun; 36(6):4133-41. PubMed ID: 25589463
[TBL] [Abstract][Full Text] [Related]
14. DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis.
Feng T; Li S; Zhao G; Li Q; Yuan H; Zhang J; Gu R; Ou D; Guo Y; Kou Q; Wang Q; Li K; Lin P
Cell Oncol (Dordr); 2023 Oct; 46(5):1235-1252. PubMed ID: 37052853
[TBL] [Abstract][Full Text] [Related]
15. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway.
Chen J; Ding C; Chen Y; Hu W; Yu C; Peng C; Feng X; Cheng Q; Wu W; Lu Y; Xie H; Zhou L; Wu J; Zheng S
Cancer Lett; 2021 Apr; 502():154-165. PubMed ID: 33340617
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
17. SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2.
Zhang N; Zhang H; Liu Y; Su P; Zhang J; Wang X; Sun M; Chen B; Zhao W; Wang L; Wang H; Moran MS; Haffty BG; Yang Q
Cell Death Differ; 2019 May; 26(5):843-859. PubMed ID: 29988076
[TBL] [Abstract][Full Text] [Related]
18. Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling.
Ma APY; Yeung CLS; Tey SK; Mao X; Wong SWK; Ng TH; Ko FCF; Kwong EML; Tang AHN; Ng IO; Cai SH; Yun JP; Yam JWP
Cancer Res; 2021 Jul; 81(13):3679-3692. PubMed ID: 33975883
[TBL] [Abstract][Full Text] [Related]
19. AUP1 regulates lipid metabolism and induces lipid accumulation to accelerate the progression of renal clear cell carcinoma.
Chen C; Zhao W; Lu X; Ma Y; Zhang P; Wang Z; Cui Z; Xia Q
Cancer Sci; 2022 Aug; 113(8):2600-2615. PubMed ID: 35633317
[TBL] [Abstract][Full Text] [Related]
20. RNF20 Suppresses Tumorigenesis by Inhibiting the SREBP1c-PTTG1 Axis in Kidney Cancer.
Lee JH; Jeon YG; Lee KH; Lee HW; Park J; Jang H; Kang M; Lee HS; Cho HJ; Nam DH; Kwak C; Kim JB
Mol Cell Biol; 2017 Nov; 37(22):. PubMed ID: 28827316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
